Entities / Company
Relay Therapeutics.
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 41
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.Some support1 report2 developments inside
-
Relay Therapeutics and Krystal Biotech are both identified as mid-cap healthcare companies.Some support1 report
-
Analyst reports compare market performance factors between Relay Therapeutics and I-Mab.Some support1 report
Gone quiet
No new reports in 90+ days-
Relay Therapeutics stock trades on the Nasdaq exchange, and insider transactions have been disclosed to the SEC.Some support2 reports
-
Relay Therapeutics disclosed via legal filing with the SEC that it trades on the Nasdaq stock exchange.Some support8 reports
-
AI stocks benefit from Trump-era tariffs and onshoring, while Relay Therapeutics and OPEX report corporate updates.Some support2 reports
-
Relay Therapeutics and Donald Trump were involved in an event on August 30, 2025.Some support1 report
-
Relay Therapeutics, based in Cambridge, began using Twitter for company updates.Some support1 report
-
Relay Therapeutics underperformed the market (S&P 500) so far this year, based on data from August 8, 2025.Some support1 report
-
Sanjiv Patel was appointed President and CEO of Relay Therapeutics on August 8, 2025.Some support1 report
-
Relay Therapeutics lowered its price target following the release of its Q2 financial results.Some support1 report
-
Relay Therapeutics began using LinkedIn for company updates.Some support1 report
-
Analyst initiated coverage of Relay Therapeutics and mentioned a promising late-stage breast cancer trial at Canino.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Relay Therapeutics
Events traced to Relay Therapeutics, step by step, newest firstAround Relay Therapeutics this week
News at the entities that move Relay Therapeutics most-
SEC StructuralInsider purchase disclosed via SEC filing for Transcontinental Realty Investors, Inc. on August 6, 2026.Moves Relay Therapeutics
-
Nasdaq StructuralQumulusAI shares were listed on the Nasdaq stock exchange on October 24, 2026.Moves Relay Therapeutics
-
Raymond James Financial Mentioned togetherScotiabank and Raymond James Financial lowered price targets and trimmed holdings in Newmont Corporation shares on July 31, 2026.Moves Relay Therapeutics
-
Twitter OperationalLee Jae Myung used Twitter for direct public communication on October 19, 2026.Moves Relay Therapeutics
-
Cambridge Shared contextCambridge and Boston are seeking collaboration on transit initiatives, with advocacy for fare-free transit.Moves Relay Therapeutics
Connections
The 7 strongest of 41, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
Relay Therapeutics is subject to mandatory disclosure and regulatory oversight requirements set by the SEC.
-
Nasdaq Structural
Relay Therapeutics is a publicly traded company listed on the Nasdaq stock exchange.
-
Twitter Operational
Relay Therapeutics actively uses Twitter as a platform for receiving and following updates.
-
Zenas Operational
The evidence suggests both entities operate in the mid-cap healthcare sector and are in competition.
-
Krystal Biotech, Inc. Mentioned together
Both companies are identified as mid-cap healthcare companies.
-
Raymond James Financial Mentioned together
Raymond James Financial provided a strong-buy rating on Relay Therapeutics shares.
-
Cambridge Shared context
Relay Therapeutics is based in Cambridge, Massachusetts.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
1 eventJune 2026
11 events- A partnership involving Recursion Pharmaceuticals, Sanofi, Roche, Merck, and Relay Therapeutics diversifies pipelines across oncology and immunology, leveraging AI-driven platforms.
- Relay Therapeutics stock trades on the Nasdaq exchange, and insider transactions have been disclosed to the SEC.
- Relay Therapeutics disclosed via legal filing with the SEC that it trades on the Nasdaq stock exchange.
- AI stocks benefit from Trump-era tariffs and onshoring, while Relay Therapeutics and OPEX report corporate updates.
- Relay Therapeutics and Donald Trump were involved in an event on August 30, 2025.
- Relay Therapeutics, based in Cambridge, began using Twitter for company updates.
- Relay Therapeutics underperformed the market (S&P 500) so far this year, based on data from August 8, 2025.
- Sanjiv Patel was appointed President and CEO of Relay Therapeutics on August 8, 2025.
- Relay Therapeutics lowered its price target following the release of its Q2 financial results.
- Relay Therapeutics began using LinkedIn for company updates.
- Analyst initiated coverage of Relay Therapeutics and mentioned a promising late-stage breast cancer trial at Canino.